INVO Insider Trading (INVO Bioscience)
Insider Ownership Percentage: 7.62%
Insider Buying (Last 12 Months): $99,997.24
Insider Selling (Last 12 Months): $0.00
INVO Bioscience Share Price & Price History
Current Price: $1.11
Price Change: ▲ Price Increase of +0.02 (1.83%)
As of 05/19/2022 10:37 AM ET
Warning: The Last Value Play Gone After August?
From Oxford Club | Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.
But a key announcement in August could send this stock rocketing skyward
Get the Details Now.
INVO Bioscience Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
10/5/2021 | Andrea Goren | CFO | Buy | 30,674 | $3.26 | $99,997.24 | | |
5/10/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 1,000 | $3.76 | $3,760.00 | | |
5/6/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 1,000 | $3.85 | $3,850.00 | | |
5/4/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 2,922 | $3.85 | $11,249.70 | | |
4/27/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 3,800 | $4.44 | $16,872.00 | | |
4/19/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 5,801 | $3.64 | $21,115.64 | | |
4/16/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 9,001 | $3.83 | $34,473.83 | | |
4/14/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 17,152 | $3.95 | $67,750.40 | | |
4/12/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 13,146 | $4.00 | $52,584.00 | | |
4/8/2021 | Awm Investment Company, Inc. | Major Shareholder | Buy | 15,000 | $4.08 | $61,200.00 | | |
Stock With Great Potential
From Wealthy Millionaire | Ad
Analyst says this stock could make quick strides with its unbelievable assets.
Learn more
INVO Bioscience Institutional Trading History
Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
---|
5/17/2022 | Virtu Financial LLC | 10,797 | $29K | 0.0% | N/A | 0.089% |  |
5/12/2022 | Magnus Financial Group LLC | 18,000 | $48K | 0.0% | +80.0% | 0.149% |  |
4/12/2022 | Eidelman Virant Capital | 11,062 | $29K | 0.0% | N/A | 0.091% |  |
2/15/2022 | Connors Investor Services Inc. | 49,000 | $0.16M | 0.0% | +27.3% | 0.418% |  |
2/15/2022 | Susquehanna International Group LLP | 13,752 | $46K | 0.0% | N/A | 0.117% |  |
2/10/2022 | Magnus Financial Group LLC | 10,000 | $33K | 0.0% | N/A | 0.085% |  |
8/16/2021 | State Street Corp | 16,881 | $78K | 0.0% | N/A | 0.161% |  |
8/13/2021 | AWM Investment Company Inc. | 1,159,075 | $5.39M | 0.5% | +22.0% | 11.077% |  |
8/12/2021 | Essex Investment Management Co. LLC | 88,865 | $0.41M | 0.0% | N/A | 0.849% |  |
8/10/2021 | Connors Investor Services Inc. | 20,000 | $93K | 0.0% | N/A | 0.191% |  |
5/21/2021 | Citadel Advisors LLC | 22,721 | $98K | 0.0% | N/A | 0.217% |  |
5/19/2021 | Squarepoint Ops LLC | 32,661 | $0.14M | 0.0% | N/A | 0.313% |  |
5/18/2021 | Millennium Management LLC | 27,857 | $0.12M | 0.0% | -50.3% | 0.267% |  |
5/18/2021 | Citadel Advisors LLC | 22,721 | $98K | 0.0% | N/A | 0.218% |  |
5/13/2021 | AWM Investment Company Inc. | 950,125 | $4.11M | 0.5% | +52.0% | 9.118% |  |
5/12/2021 | Northern Trust Corp | 11,408 | $49K | 0.0% | N/A | 0.109% |  |
5/12/2021 | Geode Capital Management LLC | 81,346 | $0.35M | 0.0% | N/A | 0.781% |  |
2/12/2021 | AWM Investment Company Inc. | 625,000 | $1.88M | 0.2% | N/A | 12.616% |  |
2/5/2021 | US Bancorp DE | 10,625 | $32K | 0.0% | N/A | 0.214% |  |
Data available starting January 2016
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Read More on INVO Bioscience
Volume
100 shs
Average Volume
32,348 shs
Market Capitalization
$13.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of INVO Bioscience?
Who are the major institutional investors of INVO Bioscience?
Which major investors are buying INVO Bioscience stock?
Within the last quarter, INVO stock was acquired by institutional investors including:
- Eidelman Virant Capital
- Virtu Financial LLC
- Magnus Financial Group LLC
In the previous year, these company insiders have bought INVO Bioscience stock:
- Andrea Goren (CFO)
- Awm Investment Company, Inc (Major Shareholder)
Learn More investors buying INVO Bioscience stock.